Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma

Richard L. Piekarz, Robin Frye, Maria Turner, John J. Wright, Steven L. Allen, Mark H. Kirschbaum, Jasmine Zain, H. Miles Prince, John P. Leonard, Larisa J. Geskin, Craig Reeder, David Joske, William D. Figg, Erin R. Gardner, Seth M. Steinberg, Elaine S. Jaffe, Maryalice Stetler-Stevenson, Stephen Lade, A. Tito Fojo, Susan E. Bates

Research output: Contribution to journal › Article › peer-review

583 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences